Instructions for Polygynax
emulsion for intravaginal administration in capsules
Owner / Registrar:
Laboratoire INNOTECH INTERNATIONAL
- International Classification of Diseases (ICD-10) B37.3
- Vulvar and vaginal candidiasis (N77.1 *) N72
- Inflammatory disease of the cervix N76
- Other inflammatory diseases of the vagina and vulva Z29.2
- Another type of preventive chemotherapy
Pharmacological group Polygynax Virgo:
Drug with antibacterial and antifungal action for local use in gynecology
pharmachologic effect Polygynax Virgo:
Combined drug, the action of which is due to its constituent components. It has antibacterial, bactericidal and antifungal effects.
and polymyxin B are active against many gram-negative and gram-positive microorganisms; Streptococcus spp. and anaerobic bacteria are insensitive to these antibiotics.
has a fungicidal effect against Candida fungi.
Allergic contact eczema; with prolonged use - ototoxicity, nephrotoxicity.
special instructions Polygynax Virgo:
Before using the drug, it is necessary to take a preliminary smear and conduct a bacteriological analysis.
Application during pregnancy and lactation
Contraindications: pregnancy; lactation period.
Indication of the drug:
Nonspecific, fungal, mixed vaginitis, vulvovaginitis and cervicovaginitis
before surgical interventions in the genital area.
before intrauterine diagnostic procedures in women
How to take Polygynax:
Intravaginally, 1-2 vaginal caps. in a day; the duration of treatment is 6-12 days. If necessary, longer treatment is possible.
Storage conditions and shelf life
Keep out of the reach of children at a temperature of 15-25 ° C.